Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) In-Situ Hybridization Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global In-Situ Hybridization Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Radioactive isotopes
      • 1.3.3 Non-radioactive labels
    • 1.4 Market Segment by Application
      • 1.4.1 Global In-Situ Hybridization Market Share by Application (2019-2025)
      • 1.4.2 Cancer Diagnosis
      • 1.4.3 Immunology
      • 1.4.4 Neuroscience
      • 1.4.5 Cytology
      • 1.4.6 Infectious Diseases
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global In-Situ Hybridization Market Size
      • 2.1.1 Global In-Situ Hybridization Revenue 2014-2025
      • 2.1.2 Global In-Situ Hybridization Sales 2014-2025
    • 2.2 In-Situ Hybridization Growth Rate by Regions
      • 2.2.1 Global In-Situ Hybridization Sales by Regions 2014-2019
      • 2.2.2 Global In-Situ Hybridization Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 In-Situ Hybridization Sales by Manufacturers
      • 3.1.1 In-Situ Hybridization Sales by Manufacturers 2014-2019
      • 3.1.2 In-Situ Hybridization Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 In-Situ Hybridization Revenue by Manufacturers (2014-2019)
      • 3.2.2 In-Situ Hybridization Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global In-Situ Hybridization Market Concentration Ratio (CR5 and HHI)
    • 3.3 In-Situ Hybridization Price by Manufacturers
    • 3.4 Key Manufacturers In-Situ Hybridization Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into In-Situ Hybridization Market
    • 3.6 Key Manufacturers In-Situ Hybridization Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Radioactive isotopes Sales and Revenue (2014-2019)
      • 4.1.2 Non-radioactive labels Sales and Revenue (2014-2019)
    • 4.2 Global In-Situ Hybridization Sales Market Share by Type
    • 4.3 Global In-Situ Hybridization Revenue Market Share by Type
    • 4.4 In-Situ Hybridization Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global In-Situ Hybridization Sales by Application

    6 United States

    • 6.1 United States In-Situ Hybridization Breakdown Data by Company
    • 6.2 United States In-Situ Hybridization Breakdown Data by Type
    • 6.3 United States In-Situ Hybridization Breakdown Data by Application

    7 European Union

    • 7.1 European Union In-Situ Hybridization Breakdown Data by Company
    • 7.2 European Union In-Situ Hybridization Breakdown Data by Type
    • 7.3 European Union In-Situ Hybridization Breakdown Data by Application

    8 China

    • 8.1 China In-Situ Hybridization Breakdown Data by Company
    • 8.2 China In-Situ Hybridization Breakdown Data by Type
    • 8.3 China In-Situ Hybridization Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World In-Situ Hybridization Breakdown Data by Company
    • 9.2 Rest of World In-Situ Hybridization Breakdown Data by Type
    • 9.3 Rest of World In-Situ Hybridization Breakdown Data by Application
    • 9.4 Rest of World In-Situ Hybridization Breakdown Data by Countries
      • 9.4.1 Rest of World In-Situ Hybridization Sales by Countries
      • 9.4.2 Rest of World In-Situ Hybridization Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Abbott Laboratories
      • 10.1.1 Abbott Laboratories Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.1.4 In-Situ Hybridization Product Introduction
      • 10.1.5 Abbott Laboratories Recent Development
    • 10.2 F. Hoffmann-La Roche
      • 10.2.1 F. Hoffmann-La Roche Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.2.4 In-Situ Hybridization Product Introduction
      • 10.2.5 F. Hoffmann-La Roche Recent Development
    • 10.3 Leica Biosystems Nussloch
      • 10.3.1 Leica Biosystems Nussloch Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.3.4 In-Situ Hybridization Product Introduction
      • 10.3.5 Leica Biosystems Nussloch Recent Development
    • 10.4 Agilent Technologies
      • 10.4.1 Agilent Technologies Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.4.4 In-Situ Hybridization Product Introduction
      • 10.4.5 Agilent Technologies Recent Development
    • 10.5 Thermo Fisher Scientific
      • 10.5.1 Thermo Fisher Scientific Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.5.4 In-Situ Hybridization Product Introduction
      • 10.5.5 Thermo Fisher Scientific Recent Development
    • 10.6 Merck
      • 10.6.1 Merck Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.6.4 In-Situ Hybridization Product Introduction
      • 10.6.5 Merck Recent Development
    • 10.7 PerkinElmer
      • 10.7.1 PerkinElmer Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.7.4 In-Situ Hybridization Product Introduction
      • 10.7.5 PerkinElmer Recent Development
    • 10.8 Exiqon A/S
      • 10.8.1 Exiqon A/S Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.8.4 In-Situ Hybridization Product Introduction
      • 10.8.5 Exiqon A/S Recent Development
    • 10.9 BioGenex Laboratories
      • 10.9.1 BioGenex Laboratories Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.9.4 In-Situ Hybridization Product Introduction
      • 10.9.5 BioGenex Laboratories Recent Development
    • 10.10 Advanced Cell Diagnostics
      • 10.10.1 Advanced Cell Diagnostics Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of In-Situ Hybridization
      • 10.10.4 In-Situ Hybridization Product Introduction
      • 10.10.5 Advanced Cell Diagnostics Recent Development
    • 10.11 Bio SB

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 In-Situ Hybridization Sales Channels
      • 11.2.2 In-Situ Hybridization Distributors
    • 11.3 In-Situ Hybridization Customers

    12 Market Forecast

    • 12.1 Global In-Situ Hybridization Sales and Revenue Forecast 2019-2025
    • 12.2 Global In-Situ Hybridization Sales Forecast by Type
    • 12.3 Global In-Situ Hybridization Sales Forecast by Application
    • 12.4 In-Situ Hybridization Forecast by Regions
      • 12.4.1 Global In-Situ Hybridization Sales Forecast by Regions 2019-2025
      • 12.4.2 Global In-Situ Hybridization Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In Situ Hybridization (ISH)
      In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section.
      The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.
      Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of gene expression. The technique is particularly useful in neuroscience.
      In 2019, the market size of In-Situ Hybridization is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for In-Situ Hybridization.

      This report studies the global market size of In-Situ Hybridization, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the In-Situ Hybridization sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott Laboratories
      F. Hoffmann-La Roche
      Leica Biosystems Nussloch
      Agilent Technologies
      Thermo Fisher Scientific
      Merck
      PerkinElmer
      Exiqon A/S
      BioGenex Laboratories
      Advanced Cell Diagnostics
      Bio SB

      Market Segment by Product Type
      Radioactive isotopes
      Non-radioactive labels

      Market Segment by Application
      Cancer Diagnosis
      Immunology
      Neuroscience
      Cytology
      Infectious Diseases

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the In-Situ Hybridization status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key In-Situ Hybridization manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of In-Situ Hybridization are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now